Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The header and footer remain visible, while the main content is replaced with an access-denied message.SummaryDifference18%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting a minor version bump in the site's metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4, indicating a new page version. The change does not modify the study data or visible content.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision stamp was updated from v3.6.3 to v3.6.4, indicating a new version of the page. The visible content and behavior remain unchanged.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the page.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study record now shows an updated timestamp (2026-06-26) and a new estimated completion date (2027-03-31), along with Revision: v3.6.2, indicating an updated version of the page content.SummaryDifference0.3%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.